Adenocarcinomas of the Uterine cervix: The epidemiology of an increasing problem

Epidemiologic Reviews

Volumn 15, Issue 2, 1993, Pages 486-491

  Kjaer, Susanne Kruger ^a   Brinton, Louise A ^b  

^a Danish Cancer Registry   (Denmark)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER SCREENING; COLPOSCOPY; ETHNIC DIFFERENCE; FEMALE; HEALTH BEHAVIOR; HUMAN; OBESITY; ORAL CONTRACEPTION; PARITY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADENOCARCINOMA; CERVIX NEOPLASMS; FEMALE; HUMAN; INCIDENCE; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; PREVALENCE; RISK FACTORS; TUMOR VIRUS INFECTIONS; UNITED STATES;

EID: 0027816989     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a036131     Document Type: Article

References (75)

1. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-46.
2. Fu YS, Berek JS, Hilborne LH. Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix. Appl Pathol 1987;5:47-56.
3. Bertrand M, Likrish GM, Colgan TJ. The ana tomic distribution of cervical adenocarcinoma in situ: implications for treatment. Am J Obstet Gynecol 1987;159:21-25.
4. Jaworski RC. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol 199O;7:190-204.
5. Jaworski RC, Pacey NF, Greenberg ML, et al. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Cancer 1988;61:1171-1181.
6. Davis JR, Moon LB. Increased incidence of adenocarcinoma of the uterine cervix. Obstet Gynecol 1975;45:79-83.
7. Gallup DG, Abell MR. Invasive adenocarcinoma of the uterine cervix. Obstet Gynecol 1977;49: 596-603.
8. Shingleton HM, Gore H, Bradley DH, et al. Adenocarcinoma of the cervix. I. Clinical evaluation and pathologic features. Am J Obstet Gynecol 1981;139:799-812.
9. Tamimi HK, Figge DC. Adenocarcinoma of the uterine cervix. Gynecol Oncol 1982;13:335-336.
10. Vesterinen E, Forss M, Nieminen U. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements. Gynecol Oncol 1989;33: 49-53.
11. Weiss RJ, Lucas WE. Adenocarcinoma of the uterine cervix. Cancer 1986;57:1996-2001.
12. Peters RK, Chao A, Mack TM, et al. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986;76:423-428.
13. Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986;124: 1045-1047.
14. Devesa SS, Young JL Jr, Brinton LA, et al. Recent trends in cervix uteri cancer. Cancer 1989; 64:2184-2190.
15. Chilvers C, Mant D, Pike MC. Cervical adenocarcinoma and oral contraceptives. Br Med J 1987;295:1446-1447.
16. Eide TJ. Cancer of the uterine cervix in Norway by histologic type, 1970-84. J Natl Cancer Inst 1987;79:199-205.
17. Berek JS, Castaldo TW, Hacker NF, et al. Adenocarcinoma of the uterine cervix. Cancer 1981;48:2734-2741.
18. Milsom I, Friberg LG. Primary adenocarcinoma of the uterine cervix. A clinical study. Cancer 1983;52:942-946.
19. Silcocks PBS, Thornton-Jones H, Murphy M. Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data. Br J Cancer 1987;55:321-325.
20. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77:912-917.
21. Horowitz IR, Jacobson LP, Zucker PK, et al. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1988;31:25-31.
22. Korhonen MO. Epidemiological differences between adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1980;10:312-317.
23. Anton-Culver H, Bloss JD, Bringman D, et al. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a populationbased epidemiologic study. Am J Obstet Gynecol 1992;166:1507-1514.
24. Menczer J, Modan B, Oelsner G, et al. Adenocarcinoma of the uterine cervix in Jewish women. A distinct epidemiological entity. Cancer 1978;41:2464-2467.
25. Czernobilsky B, Rotenstreich L, Lancet M. Adenocarcinoma of the cervix in Jewish women. A clinicopathologic study of seven cases. Isr J Med Sci 1975;2:367-372.
26. Saigo PE, Cain JM, Kim WS, et al. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986;57:1584-1593.
27. Tasker JT, Collins JA. Adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 1974;118: 344-348.
28. Abad RS, Kurohara SS, Graham JB. Clinical significance of adenocarcinoma of the cervix. Am J Obstet Gynecol 1969;104:517-522.
29. Rutledge FN, Galakatos AE, Wharton JT, et al. Adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 1975;122:236-235.
30. Brinton LA, Tashima KT, Lehman HF, et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987;47:1706-1707.
31. Parazzini F, La Vecchia C, Negri E, et al. Risk factors for adenocarcinoma of the cervix: a casecontrol study. Br J Cancer 1988;57:201-204.
32. Kvale G, Heuch I, Nilssen S. Reproductive factors and risk of cervical cancer by cell type. A prospective study. Br J Cancer 1988;58:820-4.
33. Brinton LA, Reeves WC, Brenes MM, et al. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989;130:486-496.
34. Drew NC. Adenocarcinoma-in-situ of the cervix uteri associated with cervical intraepithelial neoplasia in pregnancy. Case report. Br J Obstet Gynaecol 1984;91:498-502.
35. Chumas JC, Nelson B, Mann WJ, et al. Microglandular hyperplasia of the uterine cervix. Obstet Gynecol 1985;66:406-409.
36. Czernobilsky B, Kessler I, Lancet M. Cervical adenocarcinoma in a woman on long-term contraceptives. Obstet Gynecol 1974;43:517-521.
37. Dallenbach-Hellweg G. On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age. Pathol Res Pract 1984;179:38-50.
38. Taylor HB, Irey NS, Norris HJ. Atypical endocervical hyperplasia in women taking oral contraceptives. JAMA 1967;202:637-639.
39. Ford LC, Berek JS, Lagasse LD, et al. Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva. Gynecol Oncol 1983;15:27-31.
40. Jones MW, Silverberg SG. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Obstet Gynecol 1989;73:984-989.
41. Persson E, Einhorn N, Pettersson F. A casecontrol study of oral contraceptive use in women with adenocarcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 1987;26:85-90.
42. Brinton LA, Huggins GR, Lehman HF, et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986; 38:339-344.
43. Brinton LA, Reeves WC, Brenes MM, et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol 1990;19:4-5.
44. Potischman N. Nutritional epidemiology of cervical neoplasia. J Nutr 1993;123:424-429.
45. Herrero R, Brinton LA, Reeves WC, et al. Screening for cervical cancer in Latin America: a case-control study. Int J Epidemiol 1992;21: 1050-1056.
46. Kjellgren O. The diagnostic accuracy of the vaginal smear in cancer of the uterine cervix. Acta Obstet Gynecol Scand 1955;34:249-268.
47. Rylander E. Negative smears in women developing invasive cervical cancer. Acta Obstet Gynecol Scand 1977;56:115-118.
48. Hadjimichael O, Janerich D, Lowell DM, et al. Histologic and clinical characteristics associated with rapidly progressive invasive cervical cancer: a preliminary report from the Yale Cancer Control Research Unit. Yale J Biol Med 1989;62: 345-350.
49. Gordon AN, Bornstein J, Kaufman RH, et al. Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization. Gynecol Oncol 1989;35:345-348.
50. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. Cancer Res 1988;48:993-998.
51. King LA, Tase T, Twiggs LB, et al. Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix. Cancer 1989;63:897-900.
52. Leminen A, Paavonen J, Vesterinen E, et al. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol 1991;95:647-652.
53. Young FI, Ward LM, Brown JR. Absence of human papillomavirus in cervical adenocarcinoma determined by in situ hybridisation. J Clin Pathol 1991;44:340-341.
54. Walker J, Bloss JD, Liao SY, et al. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol 1989;74:781-785.
55. Riou G, Favre M, Jeannel D, et al. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990;335:1171-1172
56. Bjersing L, Rogo K, Evander M, et al. HPV 18 and cervical adenocarcinomas. Anticancer Res 1991;2:123-127.
57. Griffin NR, Dockey D, Lewis FA, et al. Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization. Int J Gynecol Pathol 1991;10:36-43.
58. Boon ME, Baak JPA, Kurver PJH, et al. Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer 1981;48:768-773.
59. Bousfield L, Pacey F, Young Q, et al. Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions. Acta Cytol 1980;24:283-296.
60. Christopherson WM, Nealon N, Gray LA. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979;44:975-983.
61. Ostor AG, Pagano R, Davoren RAM, et al. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1984;3:179-190.
62. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol 1989; 8:8-17.
63. Farnsworth A, Laverty C, Stoler MH. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1989;8:321-330.
64. Leary J, Jaworski R, Houghton R. In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix. Pathology 1991;23:85-89.
65. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia: presumed precursors of adenocarcinoma of the uterine cervix. Obstet Gynecol 1989;73:1005-1008.
66. Ireland D, Hardiman P, Monaghan JM. Adenocarcinoma of the uterine cervix: a study of 73 cases. Obstet Gynecol 1985;65:82-85.
67. Maier RC, Norris HJ. Coexistence of cervical intraepithelial neoplasia with primary adenocarcinoma of the endocervix. Obstet Gynecol, 1980, 56, 361-364
68. Korhonen MO. Adenocarcinoma of the uterine cervix. Prognosis and prognostic significance of histology. Cancer 1984;53:1760-3.
69. Barnes W, Delgado G, Kurman RJ, et al. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 1988; 29:267-273.
70. Stoler MH, Rhodes CR, Whitbeck A, et al. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992; 23:117-128.
71. Boon ME, Alons-van Kordelaar JJM, Rietveld- Scheffers PEM. Consequences of the introduction of combined spatula and cytobrush sampling for cervical cytology. Improvements in smear quality and detection rates. Acta Cytol 1986; 3:264-270.
72. Trimbos JB, Arentz NPW. The efficiency of the cytobrush versus the cotton swab in the collection of endocervical cells in cervical smears. Acta Cytol 1986;3:261-263.
73. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989;262: 931-934.
74. Higgins GD, Davy M, Rode: D, et al. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991;338:910-913.
75. De Britton RC, Hildesheim A, De Lao SL, et al. Human papillomaviruses and other influences on survival from cervical cancer in Panama. Obstet Gynecol 1993;81:19-24.